These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 282902)

  • 1. The primary product of DNA transcription in the blast cell of acute leukemia. Its characterization as an approach to the understanding of the origin of the blast crisis of chronic myeloid leukemia.
    Torelli U; Torelli G; Cadossi R; Ferrari S; Ferrari S; Montagna G; Narni F; Franchini G; Donelli A
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):325-33. PubMed ID: 282902
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological characterization of normal and leukemia-associated antigens of acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.
    Mohanakumar T; Miller DS; Anderson J; Metzgar RS
    Cancer Res; 1978 Mar; 38(3):716-22. PubMed ID: 75058
    [No Abstract]   [Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
    Takasaki Y; Robinson WA; Tan EM
    J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell population analysis of a heterogeneous blast cell crisis of chronic myelogenous leukemia.
    Pedraza MA; Mason D; Doslu FA; Marsh RA; Boblett JP
    Diagn Immunol; 1984; 2(1):19-24. PubMed ID: 6594209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of giant heterogeneous RNA molecules in acute myeloid leukemia blast cells.
    Torelli U; Torelli G; Cadossi R; Ferrari S; Ferrari S; Narni F; Montagnani G
    Cancer Res; 1976 Dec; 36(12):4631-8. PubMed ID: 1069607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single 3.7-kilobase messenger RNA hybridizes to immediate-early promoter enhancer of human cytomegalovirus in HL-60 and acute myeloid leukemia cells.
    Chang ZF; Huang DY; Lin CJ
    Cancer Res; 1991 Sep; 51(17):4724-8. PubMed ID: 1651811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
    Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
    Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia.
    Tosi S; Ballabio E; Teigler-Schlegel A; Boultwood J; Bruch J; Harbott J
    Genes Chromosomes Cancer; 2005 Nov; 44(3):225-32. PubMed ID: 16028218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrofocusing pattern of fucosyltransferase activity in human leukemic cells.
    Suda K; Sakamoto S; Hida K; Kano Y; Takaku F; Miura Y
    Cancer Res; 1987 Jun; 47(11):2782-6. PubMed ID: 3471318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody-dependent cytotoxicity of lymphocytes in acute myeloblastic leukemia and chronic myelocytic leukemia].
    Tishchenko LM; Guseva SA
    Eksp Onkol; 1987; 9(2):66-7. PubMed ID: 3472877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of treatment of leukemia on blast transformation of leukemia cells in vitro].
    Kiersnowska-Rogowska B; Rogowski F; Giedrojć J; Bielawiec M
    Pol Tyg Lek; 1987 Aug; 42(33):1005-7. PubMed ID: 3480508
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(A)-containing molecules in heterogeneous nuclear RNA: differences between normal lymphocytes and acute leukemia blast cells.
    Torelli U; Torelli G
    Hamatol Bluttransfus; 1974; 14():237-46. PubMed ID: 4448418
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
    Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
    Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of blast cell crisis of chronic myeloid leukemia with ICRF-159 (razoxane).
    Bakowski MT; Brearley RL; Wrigley PF
    Cancer Treat Rep; 1979; 63(11-12):2085-7. PubMed ID: 294308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.